Optiver Holding’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Optiver Holding’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,600	Closed	-$55.3K	–	530
2023 Q3	$55.3K	Sell	1,600 -56,400	-97%	-$2.2M	﹤0.01%	455
2023 Q2	$2.36M	Buy	58,000 +34,100	+143%	+$1.39M	﹤0.01%	339
2023 Q1	$923K	Buy	23,900 +6,600	+38%	+$271K	﹤0.01%	371
2022 Q4	$768K	Sell	17,300 -58,000	-77%	-$2.44M	﹤0.01%	327
2022 Q3	$3.21M	Buy	75,300 +33,400	+80%	+$1.71M	﹤0.01%	223
2022 Q2	$2.34M	Sell	41,900 -52,100	-55%	-$3.09M	﹤0.01%	212
2022 Q1	$5.83M	Buy	94,000 +37,000	+65%	+$2.26M	0.01%	161
2021 Q4	$3.09M	Buy	57,000 +35,600	+166%	+$1.86M	﹤0.01%	205
2021 Q3	$1.13M	Sell	21,400 -73,100	-77%	-$4.34M	﹤0.01%	205
2021 Q2	$6.51M	Buy	+94,500	New	+$7.21M	0.01%	133
2021 Q1	–	Hold	0	–	–	–	115

Other funds holding LKFT

Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return

Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

DCM

DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Optiver Holding's LKFT Position: Q2 2026 in Review

Optiver Holding sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q2 2026, closing a stake of 26,535 shares — an estimated $796K sold.

Optiver Holding first reported a position in LKFT in Q2 2021 and held it in 15 quarters. The position peaked at $17.4M in Q2 2022. 76 funds tracked by Wall St. Rank hold LKFT as of Q2 2026.

Optiver Holding reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q2 2026 after selling out during the quarter.
Optiver Holding sold 26,535 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2026, an estimated $796K.
Optiver Holding first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2021 and held it in 15 quarters.
Optiver Holding's Lakefront Biotherapeutics American Depositary Shares position peaked at $17.4M in Q2 2022.
76 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.